General Information

IAXO^TM compounds are Glycolipids and Benzylammonium Lipids, analogues of lipid A that are designed to act as
Toll-like-receptor 4/TLR4 antagonists that interfere with CD14 and TLR4 ligand binding in vivo and in vitro.

IAXO’s represent innovative drug candidates with therapeutic activity in rodent models of (auto/sterile)
​​​​​​​inflammatory diseases, such as neuropathic pain.